Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
^Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Staying mindful of portion sizes and making nutritious food choices will support weight loss goals
Department of Veterans Affairs healthcare data analyzed 175 health outcomes in GLP-1RA users
As of 2023, 25% of self-funded plans included weight loss treatments, with expectations to rise to 43% in 2024, indicating a shifting landscape in coverage
US$ 22.00
US$ 24.59
US$ 20.22
US$ 20.28
